LAB · Standard Biotools Inc.
$0.71
-0.04 (-4.99%)
At close · Aug 14
Market Cap
$279.67M
Shares
392.58M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $8,823,502 |
| Alex Kim | Chief Financial Officer | $4,005,165 |
| Sean Mackay | Chief Business Officer | $1,692,543 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $8,337,044 |
| Sean Mackay | Chief Business Officer | $3,177,155 |
| Alex Kim | Chief Financial Officer | $3,090,340 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $1,931,088 |
| Jeffrey Black | Former Chief Financial Officer | $1,492,297 |
| Alex Kim | Chief Financial Officer | $909,788 |
| Sean Mackay | Chief Business Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $15,895,848 |
| Alex Kim | Chief Financial Officer | $5,856,938 |
| Hanjoon Alex Kim | Chief Operating Officer | $5,856,938 |
| Stephen Christopher Linthwaite | Former President and CEO | $1,638,601 |
| Jeremy Davis | Chief Commercial Officer | $1,404,172 |
| Sean Mackay | Chief Business Officer | — |
| Jeffrey Black | Former Chief Financial Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,311,662 |
| Colin McCracken | Former Chief Commercial Officer | $1,386,353 |
| Vikram Jog | Chief Financial Officer | $1,105,664 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $920,559 |
| Bradley Kreger | Senior Vice President, Global Operations | $894,346 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,800,867 |
| Colin McCracken | Former Chief Commercial Officer | $1,657,454 |
| Vikram Jog | Chief Financial Officer | $1,443,226 |
| Bradley Kreger | Senior Vice President, Global Operations | $1,385,499 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,050,529 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | Former President and CEO | $3,713,055 |
| Colin McCracken | Former Chief Commercial Officer | $1,911,764 |
| Vikram Jog | Chief Financial Officer | $1,391,445 |
| Bradley Kreger | Senior Vice President, Global Operations | $1,352,299 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,257,775 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | President and CEO | $2,585,213 |
| Vikram Jog | Chief Financial Officer | $1,125,539 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $1,091,461 |
| Bradley Kreger | Senior Vice President, Global Operations | $995,197 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Stephen Christopher Linthwaite | President and CEO | $2,019,870 |
| Vikram Jog | Chief Financial Officer | $974,126 |
| Nicholas Khadder | Senior Vice President, General Counsel, and Secretary | $925,210 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Eli Casdin | Class I director | Appointed | 2026-06-18 |
| Thomas Carey | Class I director | Appointed | 2026-06-18 |
| Michael Egholm, Ph.D. | Class I director | Appointed | 2026-06-18 |
| Frank Witney, Ph.D. | Class III director | Appointed | 2025-06-20 |
| Kathy Hibbs | Class III director | Appointed | 2025-06-20 |
| Jeremy Davis | Chief Commercial Officer | Terminated | 2025-01-10 |
| Jonathan Mickelsen | Vice President & Chief Accounting Officer | Appointed | 2024-11-07 |
| Alex Kim | Chief Financial Officer | Appointed | 2024-11-07 |
| Alex Kim | Interim Chief Financial Officer | Appointed | 2024-07-31 |
| Jeffrey Black | Senior Vice President and Chief Financial Officer | Resigned | 2024-07-31 |
| Fenel M. Eloi | Class II director | Appointed | 2024-07-01 |
| Troy Cox | Class II director | Appointed | 2024-07-01 |
| Tom Carey | Chairperson of the Standard BioTools Board | Appointed | 2024-01-05 |
| Troy Cox | member of the Standard BioTools Board | Appointed | 2024-01-05 |
| Kathy Hibbs | member of the Standard BioTools Board | Appointed | 2024-01-05 |
| Tom Carey | member of the Standard BioTools Board | Appointed | 2024-01-05 |
| Martin Madaus, Ph.D. | member of Standard BioTools' board of directors | Resigned | 2024-01-05 |
| Laura Clague | member of Standard BioTools' board of directors | Resigned | 2024-01-05 |
| Carlos Paya, M.D., Ph.D. | member of Standard BioTools' board of directors | Resigned | 2024-01-05 |
| Eli Casdin | B-1 Director | Appointed | 2023-06-16 |
| Martin D. Madaus | B-2 Director | Appointed | 2023-06-16 |
| Fenel M. Eloi | Class I director | Appointed | 2023-06-16 |
| Michael Egholm, Ph.D. | Class I director | Appointed | 2023-06-16 |
| Vikram Jog | Special Advisor to the CEO | Appointed | 2023-05-15 |
| Jeffrey Black | Senior Vice President and Chief Financial Officer | Appointed | 2023-05-15 |
Key facts
CIK
1162194
CUSIP
34385P108
13F (30d)
141 filings
137 filers
Visit website
Investor relations